The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features,…

The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's…

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease.…

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to…

MND-SMART is investigating whether selected drugs can slow down the progression of motor neuron disease (MND) and improve survival. The…

Jo-Ann Burns says her daughter Nicola wasn't told about Sudden Unexpected Death in Epilepsy.